SiteOne Therapeutics Raises $15M
San Francisco- and Bozeman, Montana-based SiteOne Therapeutics said on Friday that it has raised $15M in a Series B investment round. The funding was led by Amgen, and also included Next Frontier and other investors. SiteOne is developing no-opioid analgesics, aimed at treating chronic pain without causing addition. The company had its headquarters in Montana, but has its research operations in San Francisco.
posted on Monday, January 9, 2017 (Link to more information)
Related companies:
SiteOne Therapeutics, Inc.
Related stories:
> Stanford Spinout SiteOne Therapeutics Gets Funding
> Arete Therapeutics Raises $35M
> Nuon Therapeutics Raises $27M
> Lead Therapeutics Raises $17M
> Emerald Therapeutics Raises $13.5M For Robotic Wet Labs
silicontap.com Home